PTK2 and telomere syndrome: Using FAK inhibitor (PF573228), the degree of keratinocyte migration in both control and STS treated cells were suppressed (3.64- and 7.11-fold reduction in the Ctrl and STS treatment, respectively, Fig. 1D).